The United States is experiencing a sustained measles outbreak, marking a worrying reversal after decades of near-elimination. As of March 2026, the disease has been circulating continuously for over a year, beginning with a prolonged outbreak in Texas (January-August 2025) and spreading to ongoing outbreaks in Utah/Arizona and South Carolina. Thirty states have reported cases this year alone, with confirmed infections already exceeding 1,300 – placing the country on track to surpass 2025’s figures, the highest in 35 years.
This isn’t simply a matter of a few preventable infections; it’s a critical sign of systemic failure in US infectious disease management.
Declining Immunity and Re-Emergence of Elimination
Measles’ return is directly tied to falling vaccination rates. While roughly 90% of the population has received the MMR vaccine, rates dip below 60% in some areas. Crucially, vaccination coverage has fallen below the 95% threshold needed for herd immunity since 2019-2020. The US achieved measles elimination in 2000 – defined as 12 months without continuous transmission – but is now at risk of losing that status, as Canada did in late 2025. The Pan American Health Organization postponed a decision on the US’s designation until November, but current trends suggest both the US and Mexico may lose their elimination status.
This isn’t just a statistical shift; it means measles is no longer being reliably contained, and outbreaks will continue unless vaccination rates improve.
Severe Health Consequences
The consequences extend beyond inconvenience. Three people died from measles in the US in 2025 – more than in any year since elimination. Approximately 11% of confirmed cases in 2025 required hospitalization, though the actual figure could be higher due to underreporting. Measles complications include pneumonia (potentially fatal), encephalitis (leading to deafness or intellectual disability), and long-term immune suppression.
Rarely, but significantly, some patients develop subacute sclerosing panencephalitis (SSPE) – a progressive dementia that always leads to death, sometimes years after initial infection. A recent case in Los Angeles involved a school-age child who died from SSPE after being infected as an infant.
Economic Costs
Recurring measles outbreaks impose substantial economic burdens. The cost of containing outbreaks can reach tens of thousands of dollars per case. A 2018-2019 outbreak in Washington state (72 cases) cost $3.2 million in public health response, medical expenses, and productivity losses. A sustained 1% drop in MMR coverage could cost the US billions across healthcare systems and the economy.
A Proxy for Systemic Weakness
The measles resurgence is not isolated. It reflects broader cracks in US public health infrastructure. Effective disease control relies on vaccination, rapid case detection, contact tracing, and safe treatment – the same steps needed for other infectious threats. Yet, diseases previously under control, such as whooping cough, have risen sharply since 2024.
Underlying this decline is eroding public trust in vaccines and public health institutions. Polling data indicates that less than half the population trusts the Centers for Disease Control and Prevention to provide reliable vaccine information. This erosion of trust will complicate responses to future outbreaks, pandemics, or even deliberate biological attacks.
The return of measles is a grim warning: the US is losing its ability to manage infectious disease effectively. Without rebuilding public trust and strengthening public health infrastructure, the country will face increasingly severe consequences from preventable illnesses.
